Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Wake Forest University Health Sciences
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Maryland, Baltimore
Essen Biotech
Thomas Jefferson University
Wake Forest University Health Sciences
Shenzhen University General Hospital
Columbia University
University of California, Davis
Hellenic Society of Hematology
Xuzhou Medical University
Hellenic Society of Hematology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Hellenic Society of Hematology
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Alliance for Clinical Trials in Oncology
University of Maryland, Baltimore
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
University Hospital Southampton NHS Foundation Trust
University of Chicago
PrECOG, LLC.
Mayo Clinic
Masonic Cancer Center, University of Minnesota
University of Arkansas
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Turin, Italy
Nantes University Hospital
Singapore General Hospital
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
University of Tennessee
Asan Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Northwestern University
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center